ORGANOGENESIS HOLDINGS INC. Stock-Based Compensation
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Stock-Based Compensation of $6.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.05M, a 20.06% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.64M, a 7.99% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.32M, a 49.57% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.06M, a 13.02% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $13.30M, a 25.71% increase from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $10.58M, a 17.59% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $9.00M, a 37.30% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $6.55M, a 69.57% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.69M 10-Q · filed 2026-08-06 | $11.01M derived: sum of 3 quarters · filed 2026-08-06 | $14.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.64M 10-Q · filed 2026-05-07 | $7.96M derived: sum of 2 quarters · filed 2026-05-07 | $11.03M derived: sum of 3 quarters · filed 2026-05-07 | $13.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.39M derived: sum of 2 quarters · filed 2026-02-26 | $9.93M derived: sum of 3 quarters · filed 2026-08-06 | $13.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.61M derived: sum of 2 quarters · filed 2026-08-06 | $8.97M 10-Q · filed 2025-11-06 | $11.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.91M 10-Q · filed 2026-08-06 | $8.80M derived: sum of 3 quarters · filed 2026-08-06 | $11.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.37M 10-Q · filed 2026-05-07 | $6.26M derived: sum of 2 quarters · filed 2026-05-07 | $8.97M derived: sum of 3 quarters · filed 2026-05-07 | $11.54M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.60M derived: sum of 2 quarters · filed 2026-02-26 | $8.17M derived: sum of 3 quarters · filed 2026-02-26 | $10.58M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.28M derived: sum of 2 quarters · filed 2025-11-06 | $7.69M 10-Q · filed 2025-11-06 | $10.05M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.97M 10-Q · filed 2025-08-07 | $7.34M derived: sum of 3 quarters · filed 2026-02-26 | $9.76M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.41M 10-Q · filed 2025-05-08 | $4.77M derived: sum of 2 quarters · filed 2026-02-26 | $7.19M derived: sum of 3 quarters · filed 2026-02-26 | $9.49M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.78M derived: sum of 2 quarters · filed 2026-02-26 | $7.08M derived: sum of 3 quarters · filed 2026-02-26 | $9.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.72M derived: sum of 2 quarters · filed 2024-11-12 | $6.63M 10-Q · filed 2024-11-12 | $8.48M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.21M 10-Q · filed 2024-08-08 | $6.07M derived: sum of 3 quarters · filed 2025-02-27 | $7.77M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.91M 10-Q · filed 2024-05-09 | $3.77M derived: sum of 2 quarters · filed 2025-02-27 | $5.47M derived: sum of 3 quarters · filed 2025-02-27 | $7.16M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.56M derived: sum of 2 quarters · filed 2025-02-27 | $5.25M derived: sum of 3 quarters · filed 2025-02-27 | $6.55M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.39M derived: sum of 2 quarters · filed 2023-11-09 | $4.70M 10-Q · filed 2023-11-09 | $5.78M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.00M 10-Q · filed 2023-08-09 | $4.08M derived: sum of 3 quarters · filed 2024-02-29 | $5.12M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.30M 10-Q · filed 2023-05-10 | $2.39M derived: sum of 2 quarters · filed 2024-02-29 | $3.43M derived: sum of 3 quarters · filed 2024-02-29 | $4.47M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.12M derived: sum of 2 quarters · filed 2024-02-29 | $3.17M derived: sum of 3 quarters · filed 2024-02-29 | $3.86M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.08M derived: sum of 2 quarters · filed 2022-11-09 | $2.78M 10-Q · filed 2022-11-09 | $3.28M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.74M 10-Q · filed 2022-08-09 | $2.24M derived: sum of 3 quarters · filed 2023-03-01 | $2.72M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $698.00K 10-Q · filed 2022-05-10 | $1.20M derived: sum of 2 quarters · filed 2023-03-01 | $1.68M derived: sum of 3 quarters · filed 2023-03-01 | $2.15M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $983.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.45M derived: sum of 3 quarters · filed 2023-03-01 | $1.66M 10-K · filed 2023-03-01 |
| 2020-09-30 | $486.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $955.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.16M 10-Q · filed 2021-11-09 | $1.40M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $678.00K 10-Q · filed 2021-08-09 | $914.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.16M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $209.00K 10-Q · filed 2021-05-11 | $445.00K derived: sum of 2 quarters · filed 2022-03-01 | $687.00K derived: sum of 3 quarters · filed 2022-03-01 | $921.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $478.00K derived: sum of 2 quarters · filed 2022-03-01 | $712.00K derived: sum of 3 quarters · filed 2022-03-01 | $936.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $476.00K derived: sum of 2 quarters · filed 2020-11-09 | $700.00K 10-Q · filed 2020-11-09 | $955.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $458.00K 10-Q · filed 2020-08-10 | $713.00K derived: sum of 3 quarters · filed 2021-03-16 | $965.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $224.00K 10-Q · filed 2020-05-11 | $479.00K derived: sum of 2 quarters · filed 2021-03-16 | $731.00K derived: sum of 3 quarters · filed 2021-03-16 | $982.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $507.00K derived: sum of 2 quarters · filed 2021-03-16 | $758.00K derived: sum of 3 quarters · filed 2021-03-16 | $1.07M 10-K · filed 2021-03-16 |
| 2018-09-30 | $252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $503.00K derived: sum of 2 quarters · filed 2019-11-12 | $820.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $568.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $317.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $919.00K 10-K · filed 2020-03-09 | |||
| 2016-12-31 | $473.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |